These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 27543298)

  • 21. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency.
    Arrant AE; Nicholson AM; Zhou X; Rademakers R; Roberson ED
    Mol Neurodegener; 2018 Jun; 13(1):32. PubMed ID: 29929528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.
    Finch N; Carrasquillo MM; Baker M; Rutherford NJ; Coppola G; Dejesus-Hernandez M; Crook R; Hunter T; Ghidoni R; Benussi L; Crook J; Finger E; Hantanpaa KJ; Karydas AM; Sengdy P; Gonzalez J; Seeley WW; Johnson N; Beach TG; Mesulam M; Forloni G; Kertesz A; Knopman DS; Uitti R; White CL; Caselli R; Lippa C; Bigio EH; Wszolek ZK; Binetti G; Mackenzie IR; Miller BL; Boeve BF; Younkin SG; Dickson DW; Petersen RC; Graff-Radford NR; Geschwind DH; Rademakers R
    Neurology; 2011 Feb; 76(5):467-74. PubMed ID: 21178100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane orientation and subcellular localization of transmembrane protein 106B (TMEM106B), a major risk factor for frontotemporal lobar degeneration.
    Lang CM; Fellerer K; Schwenk BM; Kuhn PH; Kremmer E; Edbauer D; Capell A; Haass C
    J Biol Chem; 2012 Jun; 287(23):19355-65. PubMed ID: 22511793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains.
    Josephs KA; Murray ME; Tosakulwong N; Weigand SD; Serie AM; Perkerson RB; Matchett BJ; Jack CR; Knopman DS; Petersen RC; Parisi JE; Petrucelli L; Baker M; Rademakers R; Whitwell JL; Dickson DW
    Acta Neuropathol; 2019 Feb; 137(2):227-238. PubMed ID: 30604226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes.
    T Vicente C; Perneel J; Wynants S; Heeman B; Van den Broeck M; Baker M; Cheung S; Faura J; Mackenzie IRA; Rademakers R
    Brain; 2023 Oct; 146(10):4055-4064. PubMed ID: 37100087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations and C9orf72 repeat expansions.
    Lattante S; Le Ber I; Galimberti D; Serpente M; Rivaud-Péchoux S; Camuzat A; Clot F; Fenoglio C; ; Scarpini E; Brice A; Kabashi E
    Neurobiol Aging; 2014 Nov; 35(11):2658.e1-2658.e5. PubMed ID: 25085782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Lysosomal Trafficking Transmembrane Protein 106B Is Linked to Cell Death.
    Suzuki H; Matsuoka M
    J Biol Chem; 2016 Oct; 291(41):21448-21460. PubMed ID: 27563066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study.
    Dugan AJ; Nelson PT; Katsumata Y; Shade LMP; Boehme KL; Teylan MA; Cykowski MD; Mukherjee S; Kauwe JSK; Hohman TJ; Schneider JA; ; Fardo DW
    Acta Neuropathol Commun; 2021 Sep; 9(1):152. PubMed ID: 34526147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of a protective effect of the Tmem106b "protective SNP" in the Grn knockout mouse model for frontotemporal lobar degeneration.
    Cabron AS; Borgmeyer U; Richter J; Peisker H; Gutbrod K; Dörmann P; Capell A; Damme M
    Acta Neuropathol Commun; 2023 Jan; 11(1):21. PubMed ID: 36707901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of TMEM106B potentiates lysosomal and FTLD-like pathology in progranulin-deficient mice.
    Werner G; Damme M; Schludi M; Gnörich J; Wind K; Fellerer K; Wefers B; Wurst W; Edbauer D; Brendel M; Haass C; Capell A
    EMBO Rep; 2020 Oct; 21(10):e50241. PubMed ID: 32929860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of Tmem106b is unable to ameliorate frontotemporal dementia-like phenotypes in an AAV mouse model of C9ORF72-repeat induced toxicity.
    Nicholson AM; Zhou X; Perkerson RB; Parsons TM; Chew J; Brooks M; DeJesus-Hernandez M; Finch NA; Matchett BJ; Kurti A; Jansen-West KR; Perkerson E; Daughrity L; Castanedes-Casey M; Rousseau L; Phillips V; Hu F; Gendron TF; Murray ME; Dickson DW; Fryer JD; Petrucelli L; Rademakers R
    Acta Neuropathol Commun; 2018 May; 6(1):42. PubMed ID: 29855382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function.
    Brady OA; Zheng Y; Murphy K; Huang M; Hu F
    Hum Mol Genet; 2013 Feb; 22(4):685-95. PubMed ID: 23136129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.
    Pottier C; Ren Y; Perkerson RB; Baker M; Jenkins GD; van Blitterswijk M; DeJesus-Hernandez M; van Rooij JGJ; Murray ME; Christopher E; McDonnell SK; Fogarty Z; Batzler A; Tian S; Vicente CT; Matchett B; Karydas AM; Hsiung GR; Seelaar H; Mol MO; Finger EC; Graff C; Öijerstedt L; Neumann M; Heutink P; Synofzik M; Wilke C; Prudlo J; Rizzu P; Simon-Sanchez J; Edbauer D; Roeber S; Diehl-Schmid J; Evers BM; King A; Mesulam MM; Weintraub S; Geula C; Bieniek KF; Petrucelli L; Ahern GL; Reiman EM; Woodruff BK; Caselli RJ; Huey ED; Farlow MR; Grafman J; Mead S; Grinberg LT; Spina S; Grossman M; Irwin DJ; Lee EB; Suh E; Snowden J; Mann D; Ertekin-Taner N; Uitti RJ; Wszolek ZK; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Hodges JR; Piguet O; Geier EG; Yokoyama JS; Rissman RA; Rogaeva E; Keith J; Zinman L; Tartaglia MC; Cairns NJ; Cruchaga C; Ghetti B; Kofler J; Lopez OL; Beach TG; Arzberger T; Herms J; Honig LS; Vonsattel JP; Halliday GM; Kwok JB; White CL; Gearing M; Glass J; Rollinson S; Pickering-Brown S; Rohrer JD; Trojanowski JQ; Van Deerlin V; Bigio EH; Troakes C; Al-Sarraj S; Asmann Y; Miller BL; Graff-Radford NR; Boeve BF; Seeley WW; Mackenzie IRA; van Swieten JC; Dickson DW; Biernacka JM; Rademakers R
    Acta Neuropathol; 2019 Jun; 137(6):879-899. PubMed ID: 30739198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43.
    Jiang YX; Cao Q; Sawaya MR; Abskharon R; Ge P; DeTure M; Dickson DW; Fu JY; Ogorzalek Loo RR; Loo JA; Eisenberg DS
    Nature; 2022 May; 605(7909):304-309. PubMed ID: 35344984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.
    Götzl JK; Mori K; Damme M; Fellerer K; Tahirovic S; Kleinberger G; Janssens J; van der Zee J; Lang CM; Kremmer E; Martin JJ; Engelborghs S; Kretzschmar HA; Arzberger T; Van Broeckhoven C; Haass C; Capell A
    Acta Neuropathol; 2014; 127(6):845-60. PubMed ID: 24619111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology.
    Yang HS; White CC; Klein HU; Yu L; Gaiteri C; Ma Y; Felsky D; Mostafavi S; Petyuk VA; Sperling RA; Ertekin-Taner N; Schneider JA; Bennett DA; De Jager PL
    Neuron; 2020 Aug; 107(3):496-508.e6. PubMed ID: 32526197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TMEM106B Fibrils from FTLD Patients and Healthy Controls.
    Greenwood JD; Powell WC; Walczak MA
    ACS Chem Neurosci; 2023 Aug; 14(16):2827-2829. PubMed ID: 37530644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice.
    Klein ZA; Takahashi H; Ma M; Stagi M; Zhou M; Lam TT; Strittmatter SM
    Neuron; 2017 Jul; 95(2):281-296.e6. PubMed ID: 28728022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels.
    Cruchaga C; Graff C; Chiang HH; Wang J; Hinrichs AL; Spiegel N; Bertelsen S; Mayo K; Norton JB; Morris JC; Goate A
    Arch Neurol; 2011 May; 68(5):581-6. PubMed ID: 21220649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysosome size, motility and stress response regulated by fronto-temporal dementia modifier TMEM106B.
    Stagi M; Klein ZA; Gould TJ; Bewersdorf J; Strittmatter SM
    Mol Cell Neurosci; 2014 Jul; 61():226-40. PubMed ID: 25066864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.